Cell cycle arrest and the induction of apoptosis in pancreatic cancer cells exposed to adenosine triphosphate in vitro

Oncology Reports

Volumn 9, Issue 1, 2002, Pages 113-117

  Yamada, Takayuki ^a   Okajima, Fumikazu ^a   Akbar, Mohammed ^a   Tomura, Hideaki ^a   Narita, Torao ^a   Yamada, Tatsuya ^a   Ohwada, Susumu ^a   Morishita, Yasuo ^a   Kondo, Yoichi ^a  

^a GUNMA UNIVERSITY   (Japan)

Author keywords

Adenosine triphosphate; Apoptosis; Cell cycle; Cell proliferation; Pancreatic cancer

Indexed keywords

ADENOSINE TRIPHOSPHATE; DIAGNOSTIC AGENT; DNA; FORMAZAN; MTT FORMAZAN; TETRAZOLIUM; THYMIDINE;

APOPTOSIS; ARTICLE; CELL CULTURE; CELL CYCLE; CELL DIVISION; DRUG EFFECT; FLOW CYTOMETRY; HUMAN; METABOLISM; PANCREAS TUMOR; PATHOLOGY;

ADENOSINE TRIPHOSPHATE; APOPTOSIS; CELL CYCLE; CELL DIVISION; DNA, NEOPLASM; FLOW CYTOMETRY; FORMAZANS; HUMAN; PANCREATIC NEOPLASMS; SUPPORT, NON-U.S. GOV'T; TETRAZOLIUM SALTS; THYMIDINE; TUMOR CELLS, CULTURED;

EID: 0036133917     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.9.1.113     Document Type: Article

References (24)

1. Warshaw AL and Fernandez del Castillo C: Pancreatic carcinoma. N Engl J Med 326: 455-465, 1992.
2. Aoki K, Yoshida T, Sugimura T and Terada M: Liposome-mediated in vivo gene transfer of antisense K-ras construct inhibits pancreatic tumor dissemination in the murine peritoneal cavity. Cancer Res 55: 3810-3816, 1995.
3. Erlinge D: Extracellular ATP: a growth factor for vascular smooth muscle cells. Gen Pharmacol 31: 1-8, 1998.
4. Neary J, McCarthy M, Kang Y and Zuniga S: Mitogenic signaling from P1 and P2 purinergic receptors to mitogen-activated protein kinase in human fetal astrocyte cultures. Neurosci Lett 242: 159-162, 1998. (Pubitemid 28275520)
5. Rathbone M, Middlemiss P, Andrew C, Caciagli F, Ciccarelli R, Di Iorio P and Huang R: The trophic effects of purines and purinergic signaling in pathologic reactions of astrocytes. Alzheimer Dis Assoc Disord 12: 36-45, 1998.
6. Wilden PA, Yehenew MA, Rebecca K and Stephen PH: ATP-stimulated smooth muscle cell proliferation requires independent ERK and PI3K signaling pathways. Am J Physiol 275: H1209-H1215, 1998.
7. Estrela JM, Obrador E, Navarro J, Lasso-de-la-Vega MC and Pellicer JA: Elimination of Ehrlich tumours by ATP-induced growth inhibition, glutathione depletion and X-rays. Nat Med 1: 84-88, 1995.
8. Hopfner M, Lemmer L, Jansen A, Hanski C, Riecken EO, Gavish M, Mann B, Buhr H, Glassmeier G and Scherubl H: Expression of functional P2-purinergic receptors in primary cultures of human colorectal carcinoma cells. Biochem Biophys Res Commun 251: 811-817, 1998. (Pubitemid 28512793)
9. Lasso-de-la-Vega MC, Terradez P, Obrador E, Navarro J, Pellicer JA and Estrela JM: Inhibition of cancer growth and selective glutathione depletion in Ehrlich tumour cells in vivo by extracellular ATP. Biochem J 298: 99-105, 1994.
10. Seetulsingh G and Stewart BW: Growth inhibition of HL-60 cells by extracellular ATP: concentration-dependent involvement of a P2 receptor and adenosine generation. Biochem Biophys Res Commun 250: 390-396, 1998.
11. Rapapor E, Fishman RF and Gercel C: Growth inhibition of human tumor cells in soft-agar cultures by treatment with low levels of adenosine 5′-triphosphate. Cancer Res 43: 4402-4406, 1983. (Pubitemid 13041879)
12. Rapaport E: Treatment of human tumor cells with ADP or ATP yields arrest of growth in the S phase of the cell cycle. J Cell Physiol 114:279-283, 1983.
13. Wiendl H, Schneider C and Ogilvie A: Nucleotide metabolizing ectoenzymes are upregulated in A431 cells periodically treated with cytostatic ATP leading to partial resistance without preventing apoptosis. Biochim Biophys Acta 1404: 282-298, 1998. (Pubitemid 28470530)
14. Yamada T, Okajima F, Adachi M, Ohwada S and Kondo Y: Growth dependency of a new human pancreatic cancer cell line, YAPC, on autocrine interleukin-1 alpha stimulation. Int J Cancer 76: 141-147, 1998. (Pubitemid 28164581)
15. Dawicki DD, Chatterjee D, Wyche J and Rounds S: Extra cellular ATP and adenosine cause apoptosis of pulmonary artery endothelial cells. Am J Physiol 273: L485-L494, 1997.
16. Schulze-Lohoff E, Hugo C, Rost S, Arnold S, Gruber A, Brune B and Sterzel RB: Extracellular ATP causes apoptosis and necrosis of cultured mesangial cells via P2Z/P2X7 receptors. Am J Physiol 275: F962-F971, 1998.
17. Elledge S: Cell cycle checkpoints: preventing an identity crisis. Science 274: 1664-1671, 1996.
18. Gil-Gomez G, Berns A and Brady HJ: A link between cell cycle and cell death: Bax and Bcl-2 modulate Cdk2 activation during thymocyte apoptosis. EMBO J 17: 7209-7218, 1998. (Pubitemid 29002690)
19. Steele RJ, Thompson A, Hall PA and Lane DP: The p53 tumour suppressor gene. Br J Surg 85: 1460-1467, 1998. (Pubitemid 28502570)
20. Lewis MD, Hepburn PJ and Scanion MF: Epidermal growth factor protects GH3 cells from adenosine induced growth arrest. Mol Cell Endocrinol 127: 137-142, 1997. (Pubitemid 27148374)
21. Fishman P, Bar Yehuda S and Vagman L: Adenosine and other low molecular weight factors released by muscle cells inhibit tumor cell growth. Cancer Res 58: 3181-3187, 1998. (Pubitemid 28335103)
22. Qin XQ, Livingston DM, Kaelin WG Jr and Adams PD: Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis. Proc Natl Acad Sci USA 91: 10918-10922, 1994. (Pubitemid 24349596)
23. Huang Y, Ishiko T, Nakada S, Utsugisawa T, Kato T and Yuan ZM: Role for E2F in DNA damage-induced entry of cells into S phase. Cancer Res 57: 3640-3643, 1997. (Pubitemid 27381198)
24. Sonoda S, Takeuchi M, Nakashima Y and Kuroiwa A: Safety and optimal dose of intracoronary adenosine 5′-triphosphate for the measurement of coronary flow reserve. Am Heart J 135: 621-627, 1998. (Pubitemid 28164897)